Koen Van de Vijver
Koen Van de Vijver
Professor of Gynaecological Pathology, Ghent University
Verified email at uzgent.be
Title
Cited by
Cited by
Year
Hyperthermic intraperitoneal chemotherapy in ovarian cancer
WJ Van Driel, SN Koole, K Sikorska, JH Schagen van Leeuwen, ...
New England Journal of Medicine 378 (3), 230-240, 2018
5492018
Type I and II endometrial cancers: have they different risk factors?
VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ...
Journal of Clinical Oncology 31 (20), 2607, 2013
5102013
Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311, 2017
3242017
Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma
MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ...
The Journal of pathology 223 (1), 72-80, 2011
2422011
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
1622019
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
C Denkert, S Wienert, A Poterie, S Loibl, J Budczies, S Badve, ...
Modern Pathology 29 (10), 1155-1164, 2016
1272016
The histophysiology and pathophysiology of the peritoneum
J Van Baal, KK Van de Vijver, R Nieuwland, CJF Van Noorden, ...
Tissue and Cell 49 (1), 95-105, 2017
942017
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer
RD Brandão, J Veeck, KK Van de Vijver, P Lindsey, B De Vries, ...
Breast Cancer Research 15 (2), R29, 2013
832013
Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer
CHMJ Van Elssen, PWH Frings, FJ Bot, KK Van de Vijver, MB Huls, ...
Histopathology 57 (4), 597-606, 2010
742010
Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol
KMC Cornel, RFPM Kruitwagen, B Delvoux, L Visconti, KK Van de Vijver, ...
The Journal of Clinical Endocrinology & Metabolism 97 (4), E591-E601, 2012
592012
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
LJM Van Der Putten, NCM Visser, K Van De Vijver, M Santacana, ...
British journal of cancer 115 (6), 716-724, 2016
572016
LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation
KK Van de Vijver, AM Deelder, W Jacobs, EA Van Marck, CH Hokke
Glycobiology 16 (3), 237-243, 2006
562006
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
LM Van Roozendaal, JHW de Wilt, T Van Dalen, JA Van der Hage, ...
BMC cancer 15 (1), 1-8, 2015
532015
Difficulties with diagnosis of malignancies in pregnancy
J de Haan, V Vandecaveye, SN Han, KK Van de Vijver, F Amant
Best Practice & Research Clinical Obstetrics & Gynaecology 33, 19-32, 2016
502016
No improvement in long-term survival for epithelial ovarian cancer patients: a population-based study between 1989 and 2014 in the Netherlands
M Timmermans, GS Sonke, KK Van de Vijver, MA Van der Aa, ...
European Journal of Cancer 88, 31-37, 2018
462018
Glycans of Schistosoma mansoni and keyhole limpet haemocyanin induce hepatic granulomas in vivo
KK Van de Vijver, CH Hokke, A van Remoortere, W Jacobs, AM Deelder, ...
International journal for parasitology 34 (8), 951-961, 2004
442004
Diagnostic performance of dedicated axillary T2-and diffusion-weighted MR imaging for nodal staging in breast cancer
RJ Schipper, ML Paiman, RGH Beets-Tan, PJ Nelemans, B de Vries, ...
Radiology 275 (2), 345-355, 2015
402015
E2Fs mediate a fundamental cell‐cycle deregulation in high‐grade serous ovarian carcinomas
T De Meyer, ITGW Bijsmans, KK Van de Vijver, S Bekaert, J Oosting, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
402009
Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature
M Kleppe, J Bruls, T Van Gorp, L Massuger, BFM Slangen, ...
Gynecologic oncology 133 (2), 155-158, 2014
372014
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
M Sobral-Leite, K Van de Vijver, M Michaut, R van der Linden, ...
Oncoimmunology 7 (12), e1509820, 2018
362018
The system can't perform the operation now. Try again later.
Articles 1–20